Necchi, S., Suter, M., Gaviglio, A. (2015). Personas con discapacidad: su abordaje desde miradas convergentes. Bernal, Argentina : Universidad Nacional de Quilmes. ; Personas con discapacidad: su abordaje desde miradas convergentes es una compilación de artículos pensada para acompañar desde la Universidad ese proceso de reconocimiento de derechos y construcción de conocimiento sobre las singularidades y potencialidades del sector. El presente de la educación y el trabajo, el rol de comunicación y del turismo, así como aspectos legales y filosóficos están presentes en estas páginas para quienes conocen del tema o buscan acercarse a él. Reflexiones, preguntas actualizadas y búsqueda de respuestas de una sociedad que debe abrazar a todos, y no al revés. ; Introducción / Silvia Necchi -- Filosofía sobre las personas con discapacidad / Luisa Ripa -- Los derechos de las personas con discapacidad / Luisa Ripa -- Aspectos legales que regulan los derechos de las personas con discapacidad / Liliana Bastons -- Los medios de comunicación y la discapacidad / Nancy Díaz Larrañaga -- Programas de discapacidad del Ministerio de Desarrollo Social de la provincia de Buenos Aires: su surgimiento y estado actual / Andrea Gaviglio -- Discapacidad y trabajo / María Esther Fernández -- Consideraciones en educación para personas con discapacidad / Susana Haddad -- Personas con discapacidad: algunos conceptos sobre el clivaje arte-subjetivación / Mónica Bottini -- Accesibilidad al medio: de la eliminación de barreras al diseño universal / Nora Demarchi -- Turismo accesible / Luis Grünewald y Agueda Fernández -- Convención sobre los derechos de las personas con discapacidad -- Protocolo facultativo de la Convención sobre los derechos de las personas con discapacidad -- Declaración de los derechos de las personas con retraso mental -- Los derechos humanos de las personas con discapacidades distintas (análisis del Movimiento de los Pueblos para la Educación de los Derechos Humanos) -- Convención interamericana para la eliminación de todas las formas de discriminación contra las personas con discapacidad -- Ratificación argentina de la Convención Interamericana sobre los Derechos de las Personas con Discapacidad: ley nacional Nº 25.280 -- Ley nacional Nº 22.431/81: Sistema de protección integral de los discapacitados -- Reglamentación de la ley nacional Nº 22.431 -- Ley Nº 10.592 de la Provincia de Buenos Aires: Régimen jurídico básico e integral para las personas discapacitadas.
Necchi, S., Suter, M., Gaviglio, A. (2015). Personas con discapacidad: su abordaje desde miradas convergentes. Bernal, Argentina : Universidad Nacional de Quilmes. ; Personas con discapacidad: su abordaje desde miradas convergentes es una compilación de artículos pensada para acompañar desde la Universidad ese proceso de reconocimiento de derechos y construcción de conocimiento sobre las singularidades y potencialidades del sector. El presente de la educación y el trabajo, el rol de comunicación y del turismo, así como aspectos legales y filosóficos están presentes en estas páginas para quienes conocen del tema o buscan acercarse a él. Reflexiones, preguntas actualizadas y búsqueda de respuestas de una sociedad que debe abrazar a todos, y no al revés. ; Introducción / Silvia Necchi -- Filosofía sobre las personas con discapacidad / Luisa Ripa -- Los derechos de las personas con discapacidad / Luisa Ripa -- Aspectos legales que regulan los derechos de las personas con discapacidad / Liliana Bastons -- Los medios de comunicación y la discapacidad / Nancy Díaz Larrañaga -- Programas de discapacidad del Ministerio de Desarrollo Social de la provincia de Buenos Aires: su surgimiento y estado actual / Andrea Gaviglio -- Discapacidad y trabajo / María Esther Fernández -- Consideraciones en educación para personas con discapacidad / Susana Haddad -- Personas con discapacidad: algunos conceptos sobre el clivaje arte-subjetivación / Mónica Bottini -- Accesibilidad al medio: de la eliminación de barreras al diseño universal / Nora Demarchi -- Turismo accesible / Luis Grünewald y Agueda Fernández -- Convención sobre los derechos de las personas con discapacidad -- Protocolo facultativo de la Convención sobre los derechos de las personas con discapacidad -- Declaración de los derechos de las personas con retraso mental -- Los derechos humanos de las personas con discapacidades distintas (análisis del Movimiento de los Pueblos para la Educación de los Derechos Humanos) -- Convención interamericana para la eliminación de todas las formas de discriminación contra las personas con discapacidad -- Ratificación argentina de la Convención Interamericana sobre los Derechos de las Personas con Discapacidad: ley nacional Nº 25.280 -- Ley nacional Nº 22.431/81: Sistema de protección integral de los discapacitados -- Reglamentación de la ley nacional Nº 22.431 -- Ley Nº 10.592 de la Provincia de Buenos Aires: Régimen jurídico básico e integral para las personas discapacitadas.
In this paper we study some properties of the adjusted normal cone operator of quasiconvex functions. In particular, we introduce a new notion of maximal quasimotonicity for set-valued maps different from similar ones recently appeared in the literature, and we show that it is enjoyed by this operator. Moreover, we prove the $s\times w^*$ cone upper semicontinuity of the normal cone operator in the domain of $f$ in case the set of global minima has non empty interior.
In: Horwich , A , Babjuk , M , Bellmunt , J , Bruins , H M , de Reijke , T M , de Santis , M , Gillessen , S , James , N , Maclennan , S , Palou , J , Powles , T , Ribal , M J , Shariat , S F , van der Kwast , T , Xylinas , E , Agarwal , N , Arends , T , Bamias , A , Birtle , A , Black , P C , Bochner , B H , Bolla , M , Boormans , J L , Bossi , A , Briganti , A , Brummelhuis , I , Burger , M , Castellano , D , Cathomas , R , Chiti , A , Choudhury , A , Compérat , E , Crabb , S , Culine , S , de Bari , B , DeBlok , W , de Visschere , P J L , Decaestecker , K , Dimitropoulos , K , Dominguez-Escrig , J L , Fanti , S , Fonteyne , V , Frydenberg , M , Futterer , J J , Gakis , G , Geavlete , B , Gontero , P , Grubmüller , B , Hafeez , S , Hansel , D E , Hartmann , A , Hayne , D , Henry , A M , Hernandez , V , Herr , H , Herrmann , K , Hoskin , P , Huguet , J , Jereczek-Fossa , B A , Jones , R , Kamat , A M , Khoo , V , Kiltie , A E , Krege , S , Ladoire , S , Lara , P C , Leliveld , A , Linares-Espinós , E , Løgager , V , Lorch , A , Loriot , Y , Meijer , R , Carmen Mir , M , Moschini , M , Mostafid , H , Müller , A C , Müller , C R , N'Dow , J , Necchi , A , Neuzillet , Y , Oddens , J R , Oldenburg , J , Osanto , S , Oyen , W J G , Pacheco-Figueiredo , L , Pappot , H , Patel , M I , Pieters , B R , Plass , K , Remzi , M , Retz , M , Richenberg , J , Rink , M , Roghmann , F , Rosenberg , J E , Rouprêt , M , Rouvière , O , Salembier , C , Salminen , A , Sargos , P , Sengupta , S , Sherif , A , Smeenk , R J , Smits , A , Stenzl , A , Thalmann , G N , Tombal , B , Turkbey , B , Vahr Lauridsen , S , Valdagni , R , van der Heijden , A G , van Poppel , H , Vartolomei , M D , Veskimäe , E , Vilaseca , A , Vives Rivera , F A , Wiegel , T , Wiklund , P , Williams , A , Zigeuner , R & Witjes , J A 2019 , ' EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees ' , Annals of Oncology , vol. 30 , no. 11 , pp. 1697-1727 . https://doi.org/10.1093/annonc/mdz296
Background: Although guidelines exist for advanced and variant bladder cancer management, evidence is limited/conflicting in some areas and the optimal approach remains controversial. Objective: To bring together a large multidisciplinary group of experts to develop consensus statements on controversial topics in bladder cancer management. Design: A steering committee compiled proposed statements regarding advanced and variant bladder cancer management which were assessed by 113 experts in a Delphi survey. Statements not reaching consensus were reviewed; those prioritised were revised by a panel of 45 experts before voting during a consensus conference. Setting: Online Delphi survey and consensus conference. Participants: The European Association of Urology (EAU), the European Society for Medical Oncology (ESMO), experts in bladder cancer management. Outcome measurements and statistical analysis: Statements were ranked by experts according to their level of agreement: 1–3 (disagree), 4–6 (equivocal), 7–9 (agree). A priori (level 1) consensus was defined as ≥70% agreement and ≤15% disagreement, or vice versa. In the Delphi survey, a second analysis was restricted to stakeholder group(s) considered to have adequate expertise relating to each statement (to achieve level 2 consensus). Results and limitations: Overall, 116 statements were included in the Delphi survey. Of these, 33 (28%) statements achieved level 1 consensus and 49 (42%) statements achieved level 1 or 2 consensus. At the consensus conference, 22 of 27 (81%) statements achieved consensus. These consensus statements provide further guidance across a broad range of topics, including the management of variant histologies, the role/limitations of prognostic biomarkers in clinical decision making, bladder preservation strategies, modern radiotherapy techniques, the management of oligometastatic disease and the evolving role of checkpoint inhibitor therapy in metastatic disease. Conclusions: These consensus statements provide further guidance on controversial topics in advanced and variant bladder cancer management until a time where further evidence is available to guide our approach.
BACKGROUND: Although guidelines exist for advanced and variant bladder cancer management, evidence is limited/conflicting in some areas and the optimal approach remains controversial. OBJECTIVE: To bring together a large multidisciplinary group of experts to develop consensus statements on controversial topics in bladder cancer management. DESIGN: A steering committee compiled proposed statements regarding advanced and variant bladder cancer management which were assessed by 113 experts in a Delphi survey. Statements not reaching consensus were reviewed; those prioritised were revised by a panel of 45 experts before voting during a consensus conference. SETTING: Online Delphi survey and consensus conference. PARTICIPANTS: The European Association of Urology (EAU), the European Society for Medical Oncology (ESMO), experts in bladder cancer management. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Statements were ranked by experts according to their level of agreement: 1-3 (disagree), 4-6 (equivocal), 7-9 (agree). A priori (level 1) consensus was defined as ≥70% agreement and ≤15% disagreement, or vice versa. In the Delphi survey, a second analysis was restricted to stakeholder group(s) considered to have adequate expertise relating to each statement (to achieve level 2 consensus). RESULTS AND LIMITATIONS: Overall, 116 statements were included in the Delphi survey. Of these, 33 (28%) statements achieved level 1 consensus and 49 (42%) statements achieved level 1 or 2 consensus. At the consensus conference, 22 of 27 (81%) statements achieved consensus. These consensus statements provide further guidance across a broad range of topics, including the management of variant histologies, the role/limitations of prognostic biomarkers in clinical decision making, bladder preservation strategies, modern radiotherapy techniques, the management of oligometastatic disease and the evolving role of checkpoint inhibitor therapy in metastatic disease. CONCLUSIONS: These consensus statements provide further guidance on controversial topics in advanced and variant bladder cancer management until a time where further evidence is available to guide our approach.
BACKGROUND: Although guidelines exist for advanced and variant bladder cancer management, evidence is limited/conflicting in some areas and the optimal approach remains controversial. OBJECTIVE: To bring together a large multidisciplinary group of experts to develop consensus statements on controversial topics in bladder cancer management. DESIGN: A steering committee compiled proposed statements regarding advanced and variant bladder cancer management which were assessed by 113 experts in a Delphi survey. Statements not reaching consensus were reviewed; those prioritised were revised by a panel of 45 experts prior to voting during a consensus conference. SETTING: Online Delphi survey and consensus conference. PARTICIPANTS: The European Association of Urology (EAU), the European Society for Medical Oncology (ESMO), experts in bladder cancer management. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Statements were ranked by experts according to their level of agreement: 1-3 (disagree), 4-6 (equivocal), and 7-9 (agree). A priori (level 1) consensus was defined as ≥70% agreement and ≤15% disagreement, or vice versa. In the Delphi survey, a second analysis was restricted to stakeholder group(s) considered to have adequate expertise relating to each statement (to achieve level 2 consensus). RESULTS AND LIMITATIONS: Overall, 116 statements were included in the Delphi survey. Of these statements, 33 (28%) achieved level 1 consensus and 49 (42%) achieved level 1 or 2 consensus. At the consensus conference, 22 of 27 (81%) statements achieved consensus. These consensus statements provide further guidance across a broad range of topics, including the management of variant histologies, the role/limitations of prognostic biomarkers in clinical decision making, bladder preservation strategies, modern radiotherapy techniques, the management of oligometastatic disease, and the evolving role of checkpoint inhibitor therapy in metastatic disease. CONCLUSIONS: These consensus statements provide further guidance on controversial topics in advanced and variant bladder cancer management until a time when further evidence is available to guide our approach. PATIENT SUMMARY: This report summarises findings from an international, multistakeholder project organised by the EAU and ESMO. In this project, a steering committee identified areas of bladder cancer management where there is currently no good-quality evidence to guide treatment decisions. From this, they developed a series of proposed statements, 71 of which achieved consensus by a large group of experts in the field of bladder cancer. It is anticipated that these statements will provide further guidance to health care professionals and could help improve patient outcomes until a time when good-quality evidence is available.
FMSR (Austria) ; Fonds de la Recherche Scientifique (FNRS) ; FWO (Belgium) ; Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) ; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) ; Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ) ; Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) ; MES (Bulgaria) ; CERN (China) ; Chinese Academy of Sciences (CAS) ; MoST (China) ; National Natural Science Foundation of China (NSFC) ; COLCIEN-CIAS (Colombia) ; MSES (Croatia) ; Research Promotion Foundation (RPF) ; Academy of Sciences (Estonia) ; National Institute of Chemical Physics and Biophysics (NICPB) ; Academy of Finland ; ME (Finland) ; Helsinki Institute of Physics (HIP) ; Commissariat à l'énergie atomique et aux énergies alternatives (CEA) ; Institut national de physique nucléaire et de physique des particules (IN2P3/CNRS) ; Bundesministerium für Bildung und Forschung (BMBF) ; Deutsche Forschungsgemeinschaft (DFG) ; HGF (Germany) ; General Secretariat for Research and Technology (GSRT) ; Hungarian Scientific Research Fund (OTKA) ; NKTH (Hungary) ; Department of Atomic Energy (DAE) - India ; Department of Science and Technology (DST) - India ; Institute for Research in Fundamental Sciences (IPM) ; Science Foundation Ireland (SFI) ; Istituto Nazionale di Fisica Nucleare (INFN) ; National Research Foundation of Korea (NRF) ; LAS (Lithuania) ; Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV) ; Consejo Nacional de Ciencia y Tecnología (CONACYT) ; SEP (Mexico) ; UASLP-FAI (Mexico) ; Pakistan Atomic Energy Commission (PAEC) ; SCSR (Poland) ; Fundação para a Ciência e a Tecnologia (FCT) ; Joint Institute for Nuclear Research (JINR) ; MST (Russia) ; MAE (Russia) ; MSTDS (Serbia) ; MICINN (Spain) ; Centro Nacional de Física de Partículas, Astropartículas y Nuclear (CPAN) ; Swiss Funding Agencies (Switzerland) ; NSC (Taipei) ; Scientific and Technological Research Council of Turkey (TUBITAK) ; Türkiye Atom Enerjisi Kurumu (TAEK) ; Science and Technology Facilities Council (STFC) ; DOE (USA) ; National Science Foundation (NSF) - USA ; European Union ; Leventis Foundation ; A. P. Sloan Foundation ; Alexander von Humboldt Foundation ; During autumn 2008, the Silicon Strip Tracker was operated with the full CMS experiment in a comprehensive test, in the presence of the 3.8 T magnetic field produced by the CMS superconducting solenoid. Cosmic ray muons were detected in the muon chambers and used to trigger the readout of all CMS sub-detectors. About 15 million events with a muon in the tracker were collected. The efficiency of hit and track reconstruction were measured to be higher than 99% and consistent with expectations from Monte Carlo simulation. This article details the commissioning and performance of the Silicon Strip Tracker with cosmic ray muons.